Wolfgang Miesbach on Frailty in Hemophilia: New Data Shows 3x Higher Risk
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a proud post on Linkedin:
“Frailty in Haemophilia: A Hidden Challenge for Aging Patients.
New research reveals a concerning trend: People with haemophilia (PWH) face significantly higher rates of frailty compared to the general population—nearly 3x higher in those over 65.
Alarming frailty rates:
PWH aged 50-64: 17% have frailty vs. expected ~5%
PWH aged ≥65: 29% have frailty vs. 10% general population
This means PWH are aging like they’re 15+ years older
The ‘premature aging’ effect:
30% annual fall rate in PWH (~age 40)
Equivalent to general population >75 years
58% experience polypharmacy vs 45% in peers
The Geriatric Topics Affecting PWH:
- Falls and Immobility – chronic joint damage creates mechanical instability
- Cognitive Concerns – potential links to cerebral microbleeds under investigation
- Functional Incontinence – arthropathy limits timely toilet access
- Medication Overload – complex regimens for multiple conditions
Clinical Game-Changers:
- Clinical Frailty Scale screening to be recommended for all PWH >50
- Comprehensive Geriatric Assessment proven to reverse/slow frailty
- Novel care pathways needed: physiotherapy, occupational therapy, pharmacy optimization
This research highlights the urgent need for age-appropriate care pathways in haemophilia treatment centers. As our PWH population lives longer thanks to better treatments, we must address the unique challenges of aging with a bleeding disorder.”
Amazing review by Wolfgang Miesbach, read the full article here.
Title: Frailty and frailty syndromes in persons with haemophilia: a review
Authors: William McKeown, Stephanie Taylor, Susan Shapiro
Stay informed with Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals